Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Company

Acumen Pharmaceuticals Inc Products   
385 Oyster Point Blvd #9A
South San Francisco,  CA  94080
United States
Telephone: (650) 875-7700
Fax: (650) 875-7772
URL: http://www.acumenpharm.com
Email: info@acumenpharm.com

Acumen Pharmaceuticals Incorporated, founded in 1996 and based in South San Francisco, California, is a privately held company that develops proprietary Alzheimer's disease treatments and diagnostic products. The firm conducts amyloid beta-derived diffusible ligand (ADDL) assembly blocker, binding inhibition, diagnostics, and immunotherapy research. Working with partners, the company is developing diagnostic products that detect ADDLs in blood or cerebral spinal fluid. In 2004, the firm licensed its monoclonal antibodies to Merck, supporting the development of anti-ADDL vaccines. Acumen Pharmaceuticals has licensed intellectual property from Northwestern University and the University of Southern California. The company also has collaborated with researchers at the Louisiana State University Health Sciences Center, Stanford University, and the California Institute of Technology. Acumen Pharmaceuticals has raised $3 million in capital from NeuroVentures and Biotech Value Fund.

Org. Type: Corporation Equity Type: Private
Company Status: Active Date Founded: 1996

Products:
Acumen Pharmaceuticals Inc--Company News

TecTerms:
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.